Chair SEB and Vice Chair Investor AB: Marcus Wallenberg: Family, Adaptability, and Long-Term Stewardship
Description
What is the key to sustaining a 175-year legacy in business? How do you adapt to dramatic technological changes over generations? In this episode, Nicolai sits down with Marcus Wallenberg, Chair of SEB and Vice Chair of Investor AB, to delve into the remarkable history and enduring influence of the Wallenberg family. Since 1850, the Wallenberg dynasty has played a pivotal role in shaping Swedish industry, with stakes in global giants like Ericsson, Atlas Copco, and Electrolux. Marcus shares insights on the importance of adaptability, the family`s unique approach to long-term stewardship, and the values that have guided them through
generations. Discover how the Wallenberg foundations are driving innovation through cutting-edge research and education and learn about the challenges and opportunities in modern corporate governance. This episode is a deep dive into the principles of leadership, the power of a strong network, and the future of Swedish innovation. Tune in!
The production team for this episode includes PLAN-Bs Pål Huuse and Niklas Figenschau Johansen. Background research was conducted by Isabelle Karlsson and Eirik Omre.
Watch the episode on YouTube: Norges Bank Investment Management - YouTubeWant to learn more about the fund? The fund | Norges Bank Investment Management (nbim.no)Follow Nicolai Tangen on LinkedIn: Nicolai Tangen | LinkedInFollow NBIM on LinkedIn: Norges Bank Investment Management: Administrator for bedriftsside | LinkedInFollow NBIM on Instagram: Explore Norges Bank Investment Management on Instagram
Hosted on Acast. See acast.com/privacy for more information.
Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes...
Published 11/22/24
What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s largest health care...
Published 11/20/24